Ije Nwokorie received 586 Dr. Martens Plc shares as an award (PDMR dealing notification, UK MAR art. 19)

RNS Number : 2235Y

Dr. Martens PLC

08 October 2026

Dr. Martens plc (the 'Company')

Director/PDMR Shareholding

Notification of Transactions by Directors/Persons Discharging Managerial Responsibility

The Company announces that it was notified on 08 October 2026 of the following transactions in the Company's Ordinary 1p shares undertaken by directors / persons discharging managerial responsibility ('PDMRs') under the Company's Share Incentive Plan ('SIP').

The SIP is an HMRC approved, all-employeeschemeunder which participating employees are able to purchase shares in the Company from monthly salary ('Partnership Shares') and receive allocations of free 'Matching Shares', awarded at a rate of one Matching Share for every one Partnership Share purchased by a participating employee, from the Company.

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

| | | |
| --- | --- | --- |
| 1 | Details of the person discharging managerial responsibilities/person closely associated |
| a) | Name | Ije Nwokorie |
| 2 | Reason for the notification |
| a) | Position/status | PDMR (Chief Executive Officer) |
| b) | Initial notification/Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
| a) | Name | Dr. Martens plc |
| b) | LEI | 213800QPT8YM6NQZPH28 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| a) | Description of the financial instrument, type of instrumentIdentification code | Ordinary shares of GBP 0.01ISIN: GB00BL6NGV24 |
| b) | Nature of the transaction | Acquisition of dividend shares under the SIP. |
| c) | Price(s) and volume(s) | | | | |
| --- | --- | --- |
| | Price(s) | Volume(s) |
| | £0.6780 | 308 | |
| d) | Aggregated information

-	Aggregated volume
-	Price
	n/a (single transaction)
	n/a (single transaction)
e)	Date of the transaction	7 October 2026
f)	Place of the transaction	London Stock Exchange (XLON)

| | | |
| --- | --- | --- |
| 1 | Details of the person discharging managerial responsibilities/person closely associated |
| a) | Name | Giles Wilson |
| 2 | Reason for the notification |
| a) | Position/status | PDMR (Chief Financial Officer) |
| b) | Initial notification/Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
| a) | Name | Dr. Martens plc |
| b) | LEI | 213800QPT8YM6NQZPH28 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| a) | Description of the financial instrument, type of instrumentIdentification code | Ordinary shares of GBP 0.01ISIN: GB00BL6NGV24 |
| b) | Nature of the transaction | Acquisition of dividend shares under the SIP. |
| c) | Price(s) and volume(s) | | | | |
| --- | --- | --- |
| | Price(s) | Volume(s) |
| | £0.6780 | 278 | |
| d) | Aggregated information

-	Aggregated volume
-	Price
	n/a (single transaction)
	n/a (single transaction)
e)	Date of the transaction	7 October 2026
f)	Place of the transaction	London Stock Exchange (XLON)

For further information please contact:

Rebecca Flaherty

Assistant Company Secretary

+44(0)7585 398 2165

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [\[email protected\]](https://6ix-events-pro.s3.us-east-1.amazonaws.com/cdn-cgi/l/email-protection#f3819d80b39f809694dd909c9e) or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHUWVARNKURRAA